Page last updated: 2024-10-22

albuterol and Phobic Disorders

albuterol has been researched along with Phobic Disorders in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wiwanitkit, V1

Other Studies

1 other study available for albuterol and Phobic Disorders

ArticleYear
Acute exacerbation of asthma complicated by hyperventilation in emergency department.
    The Journal of asthma : official journal of the Association for the Care of Asthma, 2010, Volume: 47, Issue:2

    Topics: Adult; Albuterol; Asthma; Emergency Service, Hospital; Female; Forced Expiratory Volume; Heart Rate;

2010